Globus Medical (GMED) : Traders are bullish on Globus Medical (GMED) as it has outperformed the S&P 500 by a wide margin of 3.23% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.93%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 5.46% in the last 1 week, and is up 3.1% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 4.41% and the 50-Day Moving Average is 0.8%.The 200 Day SMA reached 2.32%. Globus Medical, Inc. has dropped 3.93% during the last 3-month period . Year-to-Date the stock performance stands at -13.84%.
Globus Medical (NYSE:GMED): After opening at $23.66, the stock dipped to an intraday low of $23.53 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $24 and the buying power remained strong till the end. The stock closed at $23.97 for the day, a gain of 2.17% for the day session. The total traded volume was 829,217. The stocks close on the previous trading day was $23.46.
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders and spine disorders. Its products consist of two categories: Innovative Fusion and Disruptive Technologies. Innovative Fusion products comprise fusion products to treat various spinal disorders for the entire spine and can be used in various surgical approaches. Disruptive Technologies represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Companys portfolio of Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions.